Amoxicillin/Clavulanic acid Ingen Pharma

Medicinal product

(Invented) name

Amoxicillin/Clavulanic acid Ingen Pharma

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

875 mg/125 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2024-10-02

Date of renewal

Documents

5594 Amoxicillin_Clavulanic acid Ingen Pharma II PL 2025 07 15.docx

Amoxicillin_Clavulanic acid_Ingen_Pharma_875mg_125mg_viesas_AR.pdf

5594 Pakuotės lapelis 2025 07 15.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Amoksicilinas	875 mg
Klavulano rūgštis	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115207	101316	1101316	lizdinė plokštelė	N14		Receptinis	LT/1/24/5594/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-10-02	Registruotas